Related Experiment Video

Updated: May 27, 2026

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis
04:30

A Murine Model of Stent Implantation in the Carotid Artery for the Study of Restenosis

Published on: May 14, 2013

[Decreasing incidence of stent thrombosis]

G Lemesle1, C Delhaye

  • 1Service de cardiologie B, centre hémodynamique, clinique de cardiologie, hôpital cardiologique, CHRU de Lille, France. gilles lemesle@yahoo.fr

Annales De Cardiologie Et D'Angeiologie
|November 8, 2011
PubMed

Insights

Stent thrombosis (ST) is a serious complication of coronary stenting. New antiplatelet therapies significantly reduce ST incidence, particularly in acute coronary syndrome (ACS) patients.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Thrombosis Research

Background:

  • Stent thrombosis (ST) is a critical complication following percutaneous coronary intervention (PCI).
  • ST is associated with high mortality and non-fatal myocardial infarction rates.
  • Understanding ST predictors is crucial for improving patient outcomes.

Observation:

  • Platelet aggregation is central to ST pathogenesis.
  • Dual antiplatelet therapy (DAPT) with aspirin and P2Y12 inhibitors has markedly reduced ST rates.
  • This reduction is especially notable in patients with acute coronary syndrome (ACS).

Findings:

  • The incidence of ST has evolved significantly since the advent of PCI.
  • Key predictors of ST include acute coronary syndrome (ACS) and clopidogrel low response.
  • Optimizing antiplatelet therapy is vital for mitigating ST risk.

Implications:

  • Further research into ST predictors can refine treatment strategies.
  • Personalized antiplatelet regimens may further decrease ST events.
  • Continued monitoring of ST incidence is essential for evaluating PCI safety and efficacy.

Related Concept Videos

Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...